Novel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype

dc.contributor.authorKatainen Riku
dc.contributor.authorDonner Iikki
dc.contributor.authorRäisänen Maritta
dc.contributor.authorBerta Davide
dc.contributor.authorKuosmanen Anna
dc.contributor.authorKaasinen Eevi
dc.contributor.authorHietala Marja
dc.contributor.authorAaltonen Lauri A.
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id66676510
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/66676510
dc.date.accessioned2022-10-28T14:06:58Z
dc.date.available2022-10-28T14:06:58Z
dc.description.abstract<p><strong>Background</strong> Genes involved in epigenetic regulation are central for chromatin structure and gene expression. Specific mutations in these might promote carcinogenesis in several tissue types.</p><p><strong>Methods</strong> We used exome, whole-genome and Sanger sequencing to detect rare variants shared by seven affected individuals in a striking early-onset multi-cancer family. The only variant that segregated with malignancy resided in a histone demethylase KDM4C. Consequently, we went on to study the epigenetic landscape of the mutation carriers with ATAC, ChIP (chromatin immunoprecipitation) and RNA-sequencing from lymphoblastoid cell lines to identify possible pathogenic effects.</p><p><strong>Results</strong> A novel variant in KDM4C, encoding a H3K9me3 histone demethylase and transcription regulator, was found to segregate with malignancy in the family. Based on Roadmap Epigenomics Project data, differentially accessible chromatin regions between the variant carriers and controls enrich to normally H3K9me3-marked chromatin. We could not detect a difference in global H3K9 trimethylation levels. However, carriers of the variant seemed to have more trimethylated H3K9 at transcription start sites. Pathway analyses of ChIP-seq and differential gene expression data suggested that genes regulated through KDM4C interaction partner EZH2 and its interaction partner PLZF are aberrantly expressed in mutation carriers.</p><p><strong>Conclusions</strong> The apparent dysregulation of H3K9 trimethylation and KDM4C-associated genes in lymphoblastoid cells supports the hypothesis that the KDM4C variant is causative of the multi-cancer susceptibility in the family. As the variant is ultrarare, located in the conserved catalytic JmjC domain and predicted pathogenic by the majority of available in silico tools, further studies on the role of KDM4C in cancer predisposition are warranted.</p>
dc.format.pagerange644
dc.format.pagerange651
dc.identifier.eissn1468-6244
dc.identifier.jour-issn0022-2593
dc.identifier.olddbid186354
dc.identifier.oldhandle10024/169448
dc.identifier.urihttps://www.utupub.fi/handle/11111/37750
dc.identifier.urlhttps://jmg.bmj.com/content/early/2021/07/18/jmedgenet-2021-107747
dc.identifier.urnURN:NBN:fi-fe2021093048681
dc.language.isoen
dc.okm.affiliatedauthorHietala, Marja
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBMJ Publishing Group
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1136/jmedgenet-2021-107747
dc.relation.ispartofjournalJournal of Medical Genetics
dc.relation.issue7
dc.relation.volume59
dc.source.identifierhttps://www.utupub.fi/handle/10024/169448
dc.titleNovel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
jmedgenet-2021-107747.full.pdf
Size:
2.56 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF